GlassScriptPhysician profile
Lauren B Ferrell
NPI 1518345537
$5,758.40
in general payments reported to CMS, 2019-2025
44 companies · $21.77 in 2025
The $21.77 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $664 · 2021: $1,565 · 2022: $1,821 · 2023: $1,163 · 2025: $21.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $945.35 | 2020-2023 | |
| Novo Nordisk INC | $711.00 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $518.14 | 2019-2023 | Mounjaro, Jardiance |
| Amgen INC. | $325.06 | 2019-2023 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $296.59 | 2019-2023 | Farxiga |
| Astellas Pharma US INC | $233.93 | 2019-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $225.77 | 2019-2023 | Belsomra, Steglatro, Steglujan |
| Amarin Pharma, INC. | $224.03 | 2019-2022 | |
| Pfizer INC. | $206.00 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.47 | 2020-2023 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $126.50 | 2022 | |
| Daiichi Sankyo INC. | $122.65 | 2020-2022 | |
| Abbott Laboratories | $118.40 | 2022-2023 | Freestyle Libre 2 |
| Rxsight INC | $116.10 | 2022 | |
| Glaxosmithkline, LLC. | $114.88 | 2023 | Trelegy Ellipta, Arexvy, Shingrix |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.